Purification/NN
and/CC
characterization/NN
of/IN
the/DT
human/JJ
SR/NN
31747A-binding/JJ
protein/NN
./.
=====
A/DT
nuclear/JJ
membrane/NN
protein/NN
related/JJ
to/TO
yeast/NN
sterol/NN
isomerase/NN
./.

SR/NN
31747A/NN
,/,
defined/VBN
as/IN
a/DT
sigma/NN
ligand/NN
,/,
is/VBZ
a/DT
novel/JJ
immunosuppressive/JJ
agent/NN
that/WDT
blocks/VBZ
proliferation/NN
of/IN
human/JJ
and/CC
mouse/NN
lymphocytes/NNS
./.
=====
Using/VBG
a/DT
radiolabeled/JJ
chemical/JJ
probe/NN
,/,
we/PRP
here/RB
purified/VBD
a/DT
target/NN
of/IN
SR/NN
31747A/NN
and/CC
called/VBD
it/PRP
SR/NN
31747A-binding/JJ
protein/NN
(/(
SR-BP/NN
)/)
./.
=====
Purified/VBN
SR-BP/NN
retained/VBD
its/PRP$
binding/NN
properties/NNS
and/CC
migrated/VBD
on/IN
SDS-polyacrylamide/JJ
gel/NN
as/IN
a/DT
Mr/NN
28,000/CD
protein/NN
./.
=====
Cloning/NN
of/IN
the/DT
cDNA/NN
encoding/VBG
human/JJ
SR-BP/NN
shows/VBZ
an/DT
open/JJ
reading/NN
frame/NN
for/IN
a/DT
223-amino/NN
acid/NN
protein/NN
,/,
which/WDT
is/VBZ
homologous/JJ
to/TO
the/DT
recently/RB
cloned/VBN
sigma/NN
1/CD
receptor/NN
./.
=====
Interestingly/RB
,/,
the/DT
deduced/VBN
amino/NN
acid/NN
sequence/NN
was/VBD
found/VBN
to/TO
be/VB
related/JJ
to/TO
fungal/JJ
C8-C7/NN
sterol/NN
isomerase/NN
,/,
encoded/VBN
by/IN
the/DT
ERG2/NN
gene/NN
./.
=====
The/DT
ERG2/NN
gene/NN
product/NN
has/VBZ
been/VBN
identified/VBN
recently/RB
as/IN
the/DT
molecular/JJ
target/NN
of/IN
SR/NN
31747A/NN
that/WDT
mediates/VBZ
antiproliferative/JJ
effects/NNS
of/IN
the/DT
drug/NN
in/IN
yeast/NN
./.
=====
Northern/NN
blot/NN
analysis/NN
of/IN
SR-BP/NN
gene/NN
expression/NN
revealed/VBD
a/DT
single/JJ
transcript/NN
of/IN
2/CD
kilobases/NNS
which/WDT
was/VBD
widely/RB
expressed/VBN
among/IN
organs/NNS
,/,
with/IN
the/DT
highest/JJS
abundance/NN
in/IN
liver/NN
and/CC
the/DT
lowest/JJS
abundance/NN
in/IN
brain/NN
./.
=====
Subcellular/JJ
localization/NN
analysis/NN
in/IN
various/JJ
cells/NNS
,/,
using/VBG
a/DT
specific/JJ
monoclonal/JJ
antibody/NN
raised/VBN
against/IN
SR-BP/NN
,/,
demonstrated/VBD
that/IN
this/DT
protein/NN
was/VBD
associated/VBN
with/IN
the/DT
nuclear/JJ
envelope/NN
./.
=====
When/WRB
studying/VBG
the/DT
binding/NN
of/IN
SR/NN
31747A/NN
on/IN
membranes/NNS
from/IN
yeast/NN
expressing/VBG
SR-BP/NN
,/,
we/PRP
found/VBD
a/DT
pharmacological/JJ
profile/NN
of/IN
sigma/NN
1/CD
receptors/NNS
;/:
binding/NN
was/VBD
displaced/VBN
by/IN
(+)-pentazocine/NN
,/,
haloperidol/NN
,/,
and/CC
(+)-SKF/NN
10,047/CD
,/,
with/IN
(+)-SKF/NN
10, 047/CD
being/VBG
a/DT
more/RBR
potent/JJ
competitor/NN
than/IN
(-)-SKF/NN
10,047/CD
./.
=====
Scatchard/NN
plot/NN
analysis/NN
revealed/VBD
Kd/NN
values/NNS
of/IN
7.1/CD
nM/NN
and/CC
0.15/CD
nM/NN
for/IN
(+)-pentazocine/NN
and/CC
SR/NN
31747A/NN
,/,
respectively/RB
,/,
indicating/VBG
an/DT
affinity/NN
of/IN
SR-BP/NN
50-fold/RB
higher/JJR
for/IN
SR/NN
31747A/NN
than/IN
for/IN
pentazocine/NN
./.
=====
Additionally/RB
,/,
we/PRP
showed/VBD
that/IN
pentazocine/NN
,/,
a/DT
competitive/JJ
inhibitor/NN
of/IN
SR/NN
31747A/NN
binding/NN
,/,
also/RB
prevents/VBZ
the/DT
immunosuppressive/JJ
effect/NN
of/IN
SR/NN
31747A/NN
./.
=====
Taken/VBN
together/RB
,/,
these/DT
findings/NNS
strongly/RB
suggest/VBP
that/IN
SR-BP/NN
represents/VBZ
the/DT
molecular/JJ
target/NN
for/IN
SR/NN
31747A/NN
in/IN
mammalian/JJ
tissues/NNS
,/,
which/WDT
could/MD
be/VB
critical/JJ
for/IN
T/NN
cell/NN
proliferation/NN
./.